SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-22-040207
Filing Date
2022-02-14
Accepted
2022-02-14 10:24:53
Documents
1
Group Members
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUSTMACQUARIE INVESTMENT MANAGEMENT GROUP LTDMACQUARIE MANAGEMENT HOLDINGS INC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d234680dsc13ga.htm SC 13G/A 112718
  Complete submission text file 0001193125-22-040207.txt   114561
Mailing Address 50 MARTIN PLACE SYDNEY, NSW 2000 C3 2000
Business Address 50 MARTIN PLACE SYDNEY, NSW 2000 C3 2000 212.231.1000
MACQUARIE GROUP LTD (Filed by) CIK: 0001418333 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Subject) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87088 | Film No.: 22626762
SIC: 2834 Pharmaceutical Preparations